3,505 Astera Labs, Inc. $ALAB Shares Sold by Mirador Capital Partners LP

Key Points

• Mirador Capital Partners cut its Astera Labs stake by 29.8% in the third quarter, selling 3,505 shares and retaining 8,263 shares valued at approximately $2.94 million.
• Institutional investors own 60.47% of Astera Labs, while analyst sentiment remains moderately bullish, with 11 Buy ratings and 10 Holds and an average price target of $348.33.
• Astera Labs reported stronger-than-expected quarterly results, including $0.80 in EPS and $392.4 million in revenue, up 104.5% year over year; however, insiders sold 408,558 shares worth $127.3 million over the past three months.

Mirador Capital Partners LP cut its holdings in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 29.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,263 shares of the company's stock after selling 3,505 shares during the quarter. Mirador Capital Partners LP's holdings in Astera Labs were worth $2,941,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. BlackRock Inc. purchased a new stake in Astera Labs in the 2nd quarter valued at approximately $6,609,581,000. Bank of America Corp DE acquired a new stake in shares of Astera Labs during the second quarter valued at $1,061,791,000. Atreides Management LP boosted its stake in shares of Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after acquiring an additional 1,754,593 shares during the last quarter. Artisan Partners Limited Partnership purchased a new stake in Astera Labs during the 4th quarter worth about $148,980,000. Finally, Amundi raised its stake in Astera Labs by 77.9% in the 1st quarter. Amundi now owns 1,880,830 shares of the company's stock valued at $206,139,000 after purchasing an additional 823,477 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have issued reports on ALAB shares. TD Cowen reduced their target price on shares of Astera Labs from $425.00 to $375.00 and set a "hold" rating on the stock in a report on Wednesday, August 5th. Morgan Stanley boosted their price objective on shares of Astera Labs to $335.00 and gave the company an "overweight" rating in a research report on Monday, August 3rd. Bank of America upped their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the company a "neutral" rating in a research note on Tuesday, June 23rd. Weiss Ratings upgraded shares of Astera Labs from a "hold (c)" rating to a "buy (b-)" rating in a research report on Thursday. Finally, Needham & Company LLC boosted their price target on Astera Labs from $260.00 to $425.00 and gave the company a "buy" rating in a report on Wednesday, August 5th. Eleven analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat.com, Astera Labs currently has an average rating of "Moderate Buy" and an average price target of $348.33.

Insider Activity at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction on Wednesday, October 7th. The stock was sold at an average price of $376.06, for a total value of $3,382,283.64. Following the transaction, the director directly owned 2,648 shares of the company's stock, valued at approximately $995,806.88. This trade represents a 77.25% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer owned 1,119,038 shares in the company, valued at $380,864,583.30. The trade was a 7.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 408,558 shares of company stock worth $127,306,034. 10.40% of the stock is owned by corporate insiders.

Astera Labs Stock Performance

ALAB opened at $342.21 on Friday. The company's 50 day simple moving average is $317.44 and its 200 day simple moving average is $290.39. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The stock has a market capitalization of $59.37 billion, a PE ratio of 169.41 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs's revenue was up 104.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 2.70 earnings per share for the current fiscal year.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs introduced Aries 7, described as the industry’s first PCIe 7 signal-conditioning portfolio spanning copper and optical interconnects. The lineup includes retimers, redrivers, cable modules, optical drivers and optical transimpedance amplifiers, positioning the company to benefit from expanding AI infrastructure and higher-speed data-center connectivity. Astera Labs Announces Aries 7
• Positive Sentiment: Marvell’s projection that connecting AI chips could become a $37 billion business reinforced investor optimism about the broader AI-connectivity market and helped highlight Astera’s growth opportunity. However, the companies discussed in the coverage remain dependent on major customers. Marvell AI Connectivity Market Forecast
• Neutral Sentiment: Analysts and market coverage are comparing Astera’s role in connecting AI racks with Micron’s memory and system exposure. Astera offers substantial growth potential, but competition from Marvell and Credo is intensifying. Micron Versus Astera Labs
• Negative Sentiment: Northland Securities downgraded ALAB from “outperform” to “market perform,” adding pressure to the shares and signaling that the current valuation may already reflect substantial AI-related growth. Northland Securities Downgrade
• Negative Sentiment: Jim Cramer praised Astera’s business but criticized its price, reinforcing concerns that the stock’s valuation leaves limited room for execution mistakes or slower growth. Jim Cramer Discusses Astera Labs Valuation

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.